Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19317
Title: Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Agents/adverse effects/*therapeutic use,Breast Neoplasms/*drug therapy,Female,Humans,Hypertension/chemically induced,Middle Aged,Neoplasm Metastasis,Oligopeptides/adverse effects/*therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19317
ISSN: 0959-8049
Link: http://www.ncbi.nlm.nih.gov/pubmed/12565983
http://ac.els-cdn.com/S0959804902005312/1-s2.0-S0959804902005312-main.pdf?_tid=5c8dc5cec00a1c453918abd5bf75eb6d&acdnat=1333611879_d563b5bb5878caa28777e399d6ce789e
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kerbrat-2003-Phase II study of LU.pdf86.64 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons